Stem Cell-Derived Islets for Type 2 Diabetes
Since the discovery of insulin a century ago, insulin injection has been a primary treatment for both type 1 (T1D) and type 2 diabetes (T2D). T2D is a complicated disea se that is triggered by the dysfunction of insulin-producing β cells and insulin resistance in peripheral tissues. Insulin injectio...
Main Authors: | Andrew Salib, Fritz Cayabyab, Eiji Yoshihara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/9/5099 |
Similar Items
-
Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes
by: Meghan Tahbaz, et al.
Published: (2021-08-01) -
Adapting Physiology in Functional Human Islet Organogenesis
by: Eiji Yoshihara, et al.
Published: (2022-04-01) -
Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
by: Fritz Cayabyab, et al.
Published: (2021-09-01) -
Mitochondrial Carriers Regulating Insulin Secretion Profiled in Human Islets upon Metabolic Stress
by: Cecilia Jimenez-Sánchez, et al.
Published: (2020-11-01) -
Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes
by: Joan Mir-Coll, et al.
Published: (2021-02-01)